Abzena and Mabqi have announced a partnership integrating antibody discovery capabilities with development and manufacturing ...

Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with ...

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing ...

Fujiyama Power Systems IPO closes today with muted demand and zero GMP—bid now to grab your chance before the listing!

Abzena and Mabqi form strategic partnership to offer integrated discovery through development solution: San Diego, California Friday, November 7, 2025, 11:00 Hrs [IST] Abzena, the ...

Lenskart IPO and Groww IPO are attracting attention, with Lenskart concluding its subscription and Groww starting its process. Lenskart aims to raise ₹7,278 crore, while Groww targets ₹6,600 crore.

Biovectra and Revolution Biomanufacturing have announced a collaboration that grants Biovectra access to Revolution Biomanufacturing's proprietary platforms to enhance mRNA stability and translational ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

Delhi, Himachal Pradesh and Uttarakhand are among the states that have already initiated action, the people said. The ...

PhysicsWallah IPO GMP, PhysicsWallah Subscription Status Live: The wait is finally over for investors looking to participate ...

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and development of fully human antibodies, announced ...